Targets U.S. military medical logistics by combining ZenaDrone aircraft with Rattler Medical's temperature-controlled blood containers; flying prototype and demonstrations planned for summer 2027
VANCOUVER, British Columbia, Nov. 12, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA ) ("ZenaTech" or the "Company"
"Getting blood to a wounded service member quickly, and at the right temperature, is one of the most difficult logistics problems in combat medicine," said Shaun Passley, Ph.D., CEO of ZenaTech. "This MOU pairs ZenaDrone's cargo drone capability with a container system built by a team that has carried blood in the field. It also sets a defined path to a flying prototype and a demonstration with the U.S. military, extending our defense portfolio into battlefield medical logistics, applications we have long targeted for our drone platforms."
Keeping blood within a safe temperature range from the supply point to the patient is a central challenge in battlefield medicine. The planned system combines Rattler Medical's far-forward blood resupply capability with ZenaDrone's payload delivery capability. The container is expected to be carried as payload beneath a ZenaDrone aircraft and either released from the air or delivered on landing, where medical personnel would detach it. The companies plan to develop and test a prototype to determine the most effective delivery method with the prototype expected to be complete within the next three months.
According to the Business Research Company, the global medical drone delivery services market, which includes blood transfer, is expected to grow from US$510 million in 2026 to US$1.27 billion by 2030, representing a compound annual growth rate of 25.5%.
Drone-based delivery is designed to address several limitations of moving blood by ground. Aircraft can reach medical teams faster than vehicles on contested or damaged roads, and they reduce the need to put personnel at risk on resupply routes. Distributing blood across multiple drones, rather than concentrating it in a single conventional convoy, is intended to ensure safe delivery of blood supply if individual conveyance (aircraft or trucks) is lost. The approach also supports just-in-time delivery, allowing medical units to request blood as casualties occur rather than relying solely on pre-positioned stocks.
Rattler Medical was founded by Donald Young, a U.S. Army combat medic veteran, and its team brings firsthand experience in military medicine along with established relationships across the military medical community. ZenaTech expects those relationships, combined with ZenaDrone's defense engagement activities, to support the path toward demonstrations and future opportunities with U.S. military services.
"As a combat medic, I saw how much a casualty's outcome can depend on how fast blood reaches the medic treating them," said Mr. Young, Rattler Medical CEO. "Pairing our far-forward blood resupply capability with ZenaDrone's aircraft gives medics a way to receive blood where ground transport cannot reach safely, and to receive it from many aircraft at once instead of a single vehicle. Our goal is to put this capability in front of military users next year."
The companies plan to develop a flying prototype within the next two to three months. ZenaDrone is currently planning to demonstrate the system at a U.S. military facility in the summer 2027. ZenaTech expects to provide further updates as development milestones are achieved.
About ZenaTech
ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company that specializes in AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global Drone as a Service (DaaS) business, and an enterprise SaaS division of software brands. The Company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries like land surveys and inspections, driving drone-based scalable, recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for applications such as agriculture and logistics, as well as ISR, cargo, and counter-UAS for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&D initiatives.
About ZenaDrone
ZenaDrone, a subsidiary of ZenaTech, develops and manufactures AI-powered multifunction autonomous drone solutions integrating machine learning, predictive analytics, and advanced computing technologies, for government, defense, and industrial applications. This includes multifunctional drones for surveying, inspections, logistics, security, and defense applications. Its product portfolio under development includes the ZenaDrone 1000 for ISR defense and specialized cargo, the IQ Nano for indoor inventory management and security, the IQ Square for outdoor inspections and maintenance, the IQ Quad for land surveying, the IQ Aqua, for underwater applications, and the IQ Octo for precision agriculture. ZenaDrone operates three global manufacturing facilities in Arizona, Dubai, and Taiwan, and is advancing counter-UAS maritime interceptor drones and an integrated defense system.
About Rattler Medical
Rattler Medical Inc., based in Boise, Idaho, an award-winning company that develops and manufactures temperature-controlled containers designed to store and transport blood in remote and austere environments. The company was founded by Donald Young, a U.S. Army combat medic veteran, to extend the ability of military and emergency medical personnel to carry blood closer to the patient.
Contacts for more information:
Company, Investors, and Media: Linda Montgomery, ZenaTech, 312-241-1415, investors@zenatech.com
Investors: Michael Mason, CORE IR, investors@zenatech.com
News Link: https://www.zenatech.com/zenatechs-zenadrone-...ry-system/